EFFECTS OF LANSOPRAZOLE WITH OR WITHOUT AMOXICILLIN ON ULCER HEALING - RELATION TO ERADICATION OF HELICOBACTER-PYLORI

被引:23
作者
FURUTA, T
FUTAMI, H
ARAI, H
HANAI, H
KANEKO, E
机构
[1] First Department of Medicine, Hamamatsu University School of Medicine, Hamamatsu City
关键词
HELICOBACTER PYLORI; LANSOPRAZOLE; AMOXICILLIN; GASTRIC ULCER; DUODENAL ULCER; HIGH-QUALITY ULCER HEALING; AMMONIA; PEPSINOGEN I AND II; GASTRIN;
D O I
10.1097/00004836-199506002-00029
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
We studied the effects of lansoprazole with or without amoxicillin on the quality of ulcer healing in relation to eradication of Helicobacter pylori. Ulcer healing fates for lansoprazole 30 mg q.d. alone (group A) were 100% for duodenal ulcers (DU; n = 20) and 92% for gastric ulcers (GU; n = 15). The healing rates for lansoprazole 30 mg plus amoxicillin 1-2 g q.d. (group B) were 100% for both DU (n = 20) and GU (n = 12). Endoscopic findings after treatment showed that the red scar/white scar ratio in group A was 16/4 for DU and 12/1 for GU. The red scar/white scar ratio in group B was 4/16 for DU and 6/6 for GU. The numbers of H. pylori in gastric mucus did not change throughout the course of treatment in group A but decreased significantly, without H. pylori relapse, in group B. Changes in ammonia concentration in gastric juice, as well as serum gastrin and pepsinogen I and II levels, differed between group A and group B. Concomitant treatment with lansoprazole and high-dose amoxicillin eradicated H. pylori and modified gastric secretory function, resulting in high-quality ulcer healing.
引用
收藏
页码:S107 / S111
页数:5
相关论文
共 17 条
[1]   LANSOPRAZOLE - A REVIEW OF ITS PHARMACODYNAMIC AND PHARMACOKINETIC PROPERTIES AND ITS THERAPEUTIC EFFICACY IN ACID-RELATED DISORDERS [J].
BARRADELL, LB ;
FAULDS, D ;
MCTAVISH, D .
DRUGS, 1992, 44 (02) :225-250
[2]  
CHIBA N, 1992, AM J GASTROENTEROL, V87, P1716
[3]  
Furuta Takahisa, 1993, Japanese Journal of Gastroenterology, V90, P2962
[4]   EVALUATION OF CULTURAL TECHNIQUES FOR ISOLATING CAMPYLOBACTER-PYLORIDIS FROM ENDOSCOPIC BIOPSIES OF GASTRIC-MUCOSA [J].
GOODWIN, CS ;
BLINCOW, ED ;
WARREN, JR ;
WATERS, TE ;
SANDERSON, CR ;
EASTON, L .
JOURNAL OF CLINICAL PATHOLOGY, 1985, 38 (10) :1127-1131
[5]   THE MINIMUM INHIBITORY AND BACTERICIDAL CONCENTRATIONS OF ANTIBIOTICS AND ANTIULCER AGENTS AGAINST CAMPYLOBACTER-PYLORIDIS [J].
GOODWIN, CS ;
BLAKE, P ;
BLINCOW, E .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1986, 17 (03) :309-314
[6]   EFFECT OF TREATMENT OF HELICOBACTER-PYLORI INFECTION ON THE LONG-TERM RECURRENCE OF GASTRIC OR DUODENAL-ULCER - A RANDOMIZED, CONTROLLED-STUDY [J].
GRAHAM, DY ;
LEW, GM ;
KLEIN, PD ;
EVANS, DG ;
EVANS, DJ ;
SAEED, ZA ;
MALATY, HM .
ANNALS OF INTERNAL MEDICINE, 1992, 116 (09) :705-708
[7]  
HARASAWA S, 1992, 1ST EUR GASTR WEEK A
[8]   LANSOPRAZOLE, A NOVEL BENZIMIDAZOLE PROTON PUMP INHIBITOR, AND ITS RELATED-COMPOUNDS HAVE SELECTIVE ACTIVITY AGAINST HELICOBACTER-PYLORI [J].
IWAHI, T ;
SATOH, H ;
NAKAO, M ;
IWASAKI, T ;
YAMAZAKI, T ;
KUBO, K ;
TAMURA, T ;
IMADA, A .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1991, 35 (03) :490-496
[9]   CHRONIC EFFECT OF INTRAGASTRIC AMMONIA ON GASTRIC-MUCOSAL STRUCTURES IN RATS [J].
KAWANO, S ;
TSUJII, M ;
FUSAMOTO, H ;
SATO, N ;
KAMADA, T .
DIGESTIVE DISEASES AND SCIENCES, 1991, 36 (01) :33-38
[10]  
LABENZ J, 1993, AM J GASTROENTEROL, V88, P491